Scientific and Administrative Leadership
President Jane Buckner, MD, and Executive Director and Chief Operating Officer Margaret McCormick, PhD, make up BRI’s core leadership team. Drs. Buckner and McCormick guide and oversee BRI’s work and progress, and are a driving force behind our vision of a healthy immune system for everyone. Dr. Buckner has conducted research at BRI and seen patients at Virginia Mason Franciscan Health for over 20 years. Dr. McCormick has been at the helm of life science and biotech organizations for much of her career. She has been with BRI since 2017 and also serves as the vice president of research at Virginia Mason Medical Center.
Center Directors
BRI is built around four Centers of Discovery. Our Centers enable us to work collaboratively toward discoveries that improve our understanding of the immune system and lead to life-changing patient care. They also allow us to smoothly move our research between the lab and clinic, and accelerate progress toward new advances.
Our Center Directors include:
Daniel J. Campbell, PhD
Director, Center for Fundamental Immunology; Member; Principal Investigator, Campbell Lab
View Bio
Karen Cerosaletti, PhD
Director, Center for Translational Immunology; Associate Member; Principal Investigator, Cerosaletti Lab
View Bio
Carla Greenbaum, MD
Director, Center for Interventional Immunology; Member; Affiliate Faculty, University of Washington Medicine
View Bio
Adam Lacy-Hulbert, PhD
Director, Center for Systems Immunology; Associate Member; Principal Investigator, Lacy-Hulbert Lab
View Bio
External and Academic Affairs
Much of our work goes beyond BRI. We help build the next generation of immunology leaders by working with interns, graduate students and postdocs across our organization. We also team up with other research institutes and industry partners to tackle new research questions and accelerate discoveries.
Our external and academic affairs leadership includes:
Advisory Board
BRI’s advisory board is made up of community leaders including scientists, doctors and people impacted by diseases BRI studies. Together, they provide guidance and support us in achieving our mission and vision.
Our board members include:
David Aboulafia, MD
Physician, Section Head of Hematology/Oncology, Virginia Mason Franciscan Health
View Bio
Claire Bonilla
CEO, Sightlife
View Bio
Jane Buckner, MD
President, BRI; Member; Principal Investigator, Buckner Lab
View Bio
Uli Chi, PhD
Chair, Virginia Mason Franciscan Health Board of Directors
View Bio
Andrew Held
Executive Director and Banker, J.P. Morgan Private Bank
View Bio
Lauren Homme
Director, Business Development, Cumming Group
View Bio
Paul Hughes, MBA
Managing Director, Investment Banking, Blacktorch Capital
View Bio
Margaret McCormick, PhD
Executive Director & Chief Operating Officer, Administrative Services
View Bio
Kristi Pangrazio
Past President, The Rainier Club
View Bio
Ketul Patel
CEO, Virginia Mason Franciscan Health; Division President, Pacific Northwest (PNW) of CommonSpirit Health
View Bio
Ben Reiber, MBA, CFA
Vice President, Investment Management Division, Goldman Sachs & Co.
View Bio
Diane St. John, MBA
Owner, Human Resources Pacific Northwest, LLC
View Bio
David Williams, MBA
Former Executive Manager, Security Pacific Bank
View Bio
Robert Williams, PhD
Former Director, Amazon Appstore
View Bio
Steven Ziegler, PhD
Director of External Collaboration; Member, Center for Fundamental Immunology; Principal Investigator, Ziegler Lab
View Bio
Catherine Zimmerman
Mediator & Conflict Resolution Coach
View Bio
Benaroya Research Institute Awarded $4.1 Million National Institutes of Health Grant to Study Regulatory T Cells’ Function in Immune System Homeostasis
Read More
Runner Completes “2 Half Marathons, 2 Coasts, 2 Days” in support of BRI and Autoimmune Disease Awareness
Read More
